Comment from Family Research Council

Summary: The Family Research Council, a nonprofit research and educational organization, opposes the petition to remove the Mifepristone REMS program. They argue that the drug poses significant health risks to women and children and urge the FDA to instead reinstate and strengthen the original safety protocols.